We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 9,997

A question of control
  • Hill Dickinson LLP
  • United Kingdom
  • March 23 2017

In this judgment delivered by the Court of Appeal on 3 March 2017, the Court considered the potential liability of an occupier in relation to persons


High Court provides guidance on the interpretation of "defect" under the Consumer Protection Act 1987
  • Herbert Smith Freehills LLP
  • United Kingdom
  • March 23 2017

In a landmark judgment on the meaning of "defect" under the Consumer Protection Act 1987 ("the Act"), Mr Justice Hickinbottom in the High Court case


Six figure sum of compensation for failure to diagnose and repair a 4th degree tear
  • Leigh Day
  • United Kingdom
  • March 23 2017

A Young woman known only as Ms G to protect her identity, has received compensation from Ipswich Hospital for the failure to correctly diagnose and


N -v- ACCG and Ors
  • Hill Dickinson LLP
  • United Kingdom
  • March 22 2017

‘What is the role of the Court of Protection where there is a dispute between the providers or funders of health or social care services for a person


Woman gains funding for specialist mental health treatment following lengthy battle with local Clinical Commissioning Group
  • Leigh Day
  • United Kingdom
  • March 22 2017

The Clinical Commissioning Group had refused to fund Ms AA’s treatment but finally withdrew its refusal days before a hearing was due to take place


Falsified Medicines Directive to Go Full Steam Ahead Regardless of Brexit
  • Veale Wasbrough Vizards
  • European Union, United Kingdom
  • March 22 2017

The Falsified Medicines Directive is going to proceed at full pace, regardless of Brexit. Those were the comments of Martin Sawer, the Executive


NPA Fights Pharmacy Funding Cuts Due to Disproportionate Effects on Vulnerable
  • Veale Wasbrough Vizards
  • United Kingdom
  • March 22 2017

The National Pharmacy Association (NPA) is challenging the Government's proposed pharmacy funding cuts, in a High Court case. The NPA, which


Calls for MHRA to Work With EMA After Brexit or Face Drug Uptake Delays
  • Veale Wasbrough Vizards
  • European Union, United Kingdom
  • March 22 2017

There has been a series of calls for the UK pharma and medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), to


Best interests decision-makers limited to options on the table agrees Supreme Court
  • DAC Beachcroft
  • United Kingdom
  • March 22 2017

The Supreme Court has today published its judgment in the important 'available options' case of N (Appellant) v. ACCG (often referred to as the 'MN'


Landmark Supreme Court decision for Hill Dickinson in N -v- ACCG and Ors
  • Hill Dickinson LLP
  • United Kingdom
  • March 22 2017

‘What is the role of the Court of Protection where there is a dispute between the providers or funders of health or social care services for a person